Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Acquisitions: 2009-2021

Historic Acquisitions for Anika Therapeutics (ANIK) over the last 4 years, with Dec 2021 value amounting to $476,000.

  • Anika Therapeutics' Acquisitions fell 84.77% to $113,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $476,000, marking a year-over-year change of. This contributed to the annual value of $476,000 for FY2021, which is 99.50% down from last year.
  • According to the latest figures from FY2021, Anika Therapeutics' Acquisitions is $476,000, which was down 99.50% from $94.6 million recorded in FY2020.
  • In the past 5 years, Anika Therapeutics' Acquisitions ranged from a high of $94.6 million in FY2020 and a low of $476,000 during FY2021.
  • In the last 2 years, Anika Therapeutics' Acquisitions had a median value of $47.5 million in 2020 and averaged $47.5 million.
  • Data for Anika Therapeutics' Acquisitions shows a maximum YoY crashed of 99.50% (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Anika Therapeutics' Acquisitions stood at $94.6 million in 2020, then plummeted by 99.50% to $476,000 in 2021.